trending Market Intelligence /marketintelligence/en/news-insights/trending/aekxkzpqqfqslnk-kdnxdg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Cronos Group to raise C$100M via bought deal offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Cronos Group to raise C$100M via bought deal offering

Cronos Group Inc. agreed to sell 10,420,000 common shares at C$9.60 each on a bought deal basis.

The company expects to raise gross proceeds of about C$100 million through the sale, which is expected to close on or around April 6, subject to regulatory approvals.

Cronos Group plans to use C$15 million of the net proceeds for its international operations and capacity expansion, with the rest going toward general working capital purposes.

The underwriters, co-led by GMP Securities LP and BMO Capital Markets, have a 30-day overallotment option to buy up to an additional 1,563,000 shares, worth about C$15 million, on the same terms.

Toronto-based Cronos Group is a principal investment firm focused on medical cannabis producers in Canada.